18.07.2017 • News

ChemChina's Crosses 98% Syngenta Threshold

(c) Syngenta
(c) Syngenta

ChemChina has filed a petition with the appellate court in Basel, Switzerland, to cancel the remaining shares in Syngenta not already held by the company or any of its affiliates.

The Chinese company said it now controls more than 98% of the Swiss agrochemicals producer’s capital, following the purchase of additional shares.

As of May 24, at the end of the last extension period, ChemChina had acquired 92.2% of Syngenta and had begun delisting the share from the Swiss stock exchange SIX and the ADS certificates from the New York Stock Exchange

Holders of the remaining papers will receive the offer price of $465 per share following completion of the court proceedings. At this time, Syngenta said it will apply for the delisting from the SIX to become effective.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.